Business
ABI: Losses persist as regulatory hurdles delay hydrogen project; equity bolstered by new share issues
ABI: Losses persist as regulatory hurdles delay hydrogen project; equity bolstered by new share issues
About this update from Ab Igrene
Hydrogen and carbon production technology advanced, but regulatory barriers halted demo plant permits. Financials show continued losses, strengthened equity via share issues, and a strategic stake in SEID AS. Asset values remain highly dependent on future regulatory changes.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.